Revival recalls feline milk replacers over nutrient deficiencies

Revival Animal Health has launched a nationwide voluntary recall of Breeder’s Edge and Shelter’s Choice feline milk replacers after testing found inconsistent, low levels of several essential nutrients in products intended for neonatal and young kittens. The FDA published the company’s announcement on August 26, 2026, framing the issue as a potentially serious safety risk for a population that may depend entirely on milk replacer for survival and growth. (fda.gov)

According to the FDA-posted notice, the recall was triggered after third-party testing suggested a possible nutrient deficiency in one lot. Revival then conducted confirmatory testing across multiple lots, and those results were reviewed by an independent animal nutritionist on August 12, 2026. The company said the findings pointed to third-party manufacturing inconsistencies, and it has since discontinued its relationship with that contracted manufacturer. (fda.gov)

The recalled products include Shelter’s Choice Feline Milk Replacer in 1 lb., 3.5 lb., and 8 lb. sizes, and Breeder’s Edge Foster Care Feline Milk Replacer in 12 oz., 4.5 lb., and 18 lb. sizes. Affected best-by dates range from September 9, 2026, through March 12, 2028, depending on the SKU. The products were sold nationwide online and in retail pet stores, and Revival is advising customers to stop feeding them immediately and return them for a full refund. (fda.gov)

The nutrient shortfalls named in the recall, potassium, copper, folic acid, choline, and pyridoxine, matter because kittens in the first weeks of life have narrow nutritional margins and rapid growth demands. FDA said deficiencies may lead to compounding, multi-system consequences, including anemia, neurologic dysfunction, liver failure, kidney damage, skeletal disease, and cardiac compromise, and that clinical signs may appear within days to a few weeks. That warning aligns with broader neonatal nutrition guidance stressing that orphaned kittens should receive a commercial kitten-specific milk replacer, not cow’s or goat’s milk, and should be monitored closely for weight gain, hydration, and overall development. (fda.gov)

So far, Revival said no illnesses tied to the products have been confirmed, but it is investigating nine complaints involving possible gastrointestinal and bone development issues. While the company announcement does not include outside expert comment, the recall lands in a year when Revival has already appeared in FDA recall notices tied to milk replacer products, including separate canine-related actions, which may sharpen industry attention on supplier oversight and formulation control in this niche but clinically important category. That broader point is an inference based on the sequence of FDA-posted recalls, not a statement from regulators or the company. (fda.gov)

Why it matters: For veterinary professionals, especially those in shelter medicine, feline practice, emergency care, and rescue partnerships, this is more than a retail recall. Neonatal kittens often present with vague early signs, poor weight gain, lethargy, diarrhea, weakness, developmental delay, and by the time a nutrition-linked pattern is recognized, the window for preventing permanent harm may be narrow. Practices may need to ask specifically about recalled milk replacers in recent kitten histories, alert foster networks and rescue partners, and reinforce monitoring protocols for exposed kittens, including serial weights, growth assessment, and low thresholds for diagnostic workups when clinical signs emerge. (fda.gov)

What to watch: The next key developments are whether FDA posts follow-up enforcement details, whether Revival expands or narrows the affected lot list, and whether ongoing complaint investigations clarify a more consistent syndrome, particularly around GI signs or impaired bone development in bottle-fed kittens. (fda.gov)